No differences in plasma FABP4 levels were observed between COPD patients with and without airway infection [29.8 (20.4–45.0) vs. 26.1 (19.3–37.9) ng/ml, p = 0.6]. This evidence concerns the gene FABP4 and chronic obstructive pulmonary disease.